Actual NR 565-advanced pharmacology Final Exam Chamberlain
Universit Questions And Correct Detailed Answers 2026 Edition
C.Alcoholics
In which patient population is Metformin contraindicated in?
A. Diabetics with HAlc <7.0%
B. Patients older than 50
C.Alcoholics
D.Women suffering from infertility
What lab value suggests metformin might be A.eGFR<30
contraindicated?
A.eGFR <30
B.Crea 0.8
C.WBC 7.8
D.Bun 17
What medication is contraindicated to treat diabetes if a B.Thiazolidinediones
patient already has a cardiac ejection fraction rate of
40%?
A.Second Generation sulfonyureas
B.Thiazolidinediones
C.Dopamine Agonist
D.Glucosidase Inhibitor
, A.Methimazole
Sabrina is a 35-year-old female who presents with complaints of
fatigue, anxiety, and palpitations. She has a long history of obesity and
reports that she is happy that she has lost 23 pounds in the last 2
months. She also reports that she has trouble sleeping and her husband
complains that she is keeping the house too cold.
Physical exam reveals slight tachycardia at 104 bpm and a slightly
enlarged thyroid. Thyroid testing reveals
hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for
hyperthyroidism or Grave's disease?
A.Methimazole
B.Metoprolol
C.Allopurinol
D.Levothyroxine
Which of the following medications would be considered the first line C:Oral Metformin
of treatment for a newly diagnosed Diabetic patient with adequate
renal and hepatic function?
A: NovoLog Sliding Scale Insulin
B:Liraglutide (Victoza)
C:Oral Metformin
D:Glipizide
Of the following medications, which is most likely to cause B.Insulin
hypoglycemia?
A.Metformin
B.Insulin
C.Incretin mimetics
D.Thiazolidinediones
Which symptoms are most expected of a patient diagnosed D.dry skin, brittle hair, fatigue, myxedema
with hypothyroidism?
A.shortness of breath,wheezing,fatigue
B.tachycardia,insomnia,weight loss,goiter
C.irritability,anxiety, dizziness, increased sweating
D.dry pale skin, brittle hair, fatigue,myxedema
Patients with an increased risk for UTIs and genital infections or an C.Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
active diagnosis, should avoid what drug
class/es for treatment of Type II Diabetes?
A.Thiazolidinediones (Glitazones)
B.Biguanide.
C.Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D.All of the above.
, A 45-year-old patient with a history of type 2 diabetes presents to D. Metformin improves insulin sensitivity and reduces hepatic glucose production.
the clinic for a follow-up appointment.The healthcare provider has
prescribed metformin as part of
the treatment plan. Which of the following statements
regarding metformin is correct?
A.Metformin primarily stimulates insulin production from the
pancreas.
B. Metformin reduces glucose levels primarily by
decreasing insulin resistance.
C.Metformin is associated with a risk of hypoglycemia.
D.Metformin improves insulin sensitivity and reduces hepatic
glucose production.
In what part of the body are SGLT-2 (sodium-glucose cotransporter C.Renal tubules
2) inhibitors active?
A.Small intestine
B.Pancreas
C.Renal tubules
D.Stomach
Which of the following statements is not true regarding A. Sulonlyreas are safe to prescribe to pregnant and/or breast-feeding women.
sulfonylureas?
A. Sulonlyreas are safe to prescribe to pregnant and/or breast-
feeding women.
B. Patients should be educated about signsand
symptoms of hypoglycemia.
C.Sulfonylureas cause a dose-dependent reduction in
blood glucose.
D. Sulfonylureas are indicated for only patients
diagnosed with type 2 diabetes.
A 33 year old woman previously diagnosed with A.atenolol
hyperthyroidism noted have tachycardia. Which
medication should the NP add to the patients regimen?
A.atenolol
B.levothyroxine
C.lithium
D.semaglutide
Once a patient's thyroid is euthyroid and their dose can be B.every 12 months
maintained at the prescription, at what interval should
their TSH be re-checked?
A.every 18 months
B.every 12 months
C.every 6 months
D.every 24 months
Universit Questions And Correct Detailed Answers 2026 Edition
C.Alcoholics
In which patient population is Metformin contraindicated in?
A. Diabetics with HAlc <7.0%
B. Patients older than 50
C.Alcoholics
D.Women suffering from infertility
What lab value suggests metformin might be A.eGFR<30
contraindicated?
A.eGFR <30
B.Crea 0.8
C.WBC 7.8
D.Bun 17
What medication is contraindicated to treat diabetes if a B.Thiazolidinediones
patient already has a cardiac ejection fraction rate of
40%?
A.Second Generation sulfonyureas
B.Thiazolidinediones
C.Dopamine Agonist
D.Glucosidase Inhibitor
, A.Methimazole
Sabrina is a 35-year-old female who presents with complaints of
fatigue, anxiety, and palpitations. She has a long history of obesity and
reports that she is happy that she has lost 23 pounds in the last 2
months. She also reports that she has trouble sleeping and her husband
complains that she is keeping the house too cold.
Physical exam reveals slight tachycardia at 104 bpm and a slightly
enlarged thyroid. Thyroid testing reveals
hyperthyroidism or Grave's disease.
Which of the following agents is the first-line treatment for
hyperthyroidism or Grave's disease?
A.Methimazole
B.Metoprolol
C.Allopurinol
D.Levothyroxine
Which of the following medications would be considered the first line C:Oral Metformin
of treatment for a newly diagnosed Diabetic patient with adequate
renal and hepatic function?
A: NovoLog Sliding Scale Insulin
B:Liraglutide (Victoza)
C:Oral Metformin
D:Glipizide
Of the following medications, which is most likely to cause B.Insulin
hypoglycemia?
A.Metformin
B.Insulin
C.Incretin mimetics
D.Thiazolidinediones
Which symptoms are most expected of a patient diagnosed D.dry skin, brittle hair, fatigue, myxedema
with hypothyroidism?
A.shortness of breath,wheezing,fatigue
B.tachycardia,insomnia,weight loss,goiter
C.irritability,anxiety, dizziness, increased sweating
D.dry pale skin, brittle hair, fatigue,myxedema
Patients with an increased risk for UTIs and genital infections or an C.Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
active diagnosis, should avoid what drug
class/es for treatment of Type II Diabetes?
A.Thiazolidinediones (Glitazones)
B.Biguanide.
C.Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors.
D.All of the above.
, A 45-year-old patient with a history of type 2 diabetes presents to D. Metformin improves insulin sensitivity and reduces hepatic glucose production.
the clinic for a follow-up appointment.The healthcare provider has
prescribed metformin as part of
the treatment plan. Which of the following statements
regarding metformin is correct?
A.Metformin primarily stimulates insulin production from the
pancreas.
B. Metformin reduces glucose levels primarily by
decreasing insulin resistance.
C.Metformin is associated with a risk of hypoglycemia.
D.Metformin improves insulin sensitivity and reduces hepatic
glucose production.
In what part of the body are SGLT-2 (sodium-glucose cotransporter C.Renal tubules
2) inhibitors active?
A.Small intestine
B.Pancreas
C.Renal tubules
D.Stomach
Which of the following statements is not true regarding A. Sulonlyreas are safe to prescribe to pregnant and/or breast-feeding women.
sulfonylureas?
A. Sulonlyreas are safe to prescribe to pregnant and/or breast-
feeding women.
B. Patients should be educated about signsand
symptoms of hypoglycemia.
C.Sulfonylureas cause a dose-dependent reduction in
blood glucose.
D. Sulfonylureas are indicated for only patients
diagnosed with type 2 diabetes.
A 33 year old woman previously diagnosed with A.atenolol
hyperthyroidism noted have tachycardia. Which
medication should the NP add to the patients regimen?
A.atenolol
B.levothyroxine
C.lithium
D.semaglutide
Once a patient's thyroid is euthyroid and their dose can be B.every 12 months
maintained at the prescription, at what interval should
their TSH be re-checked?
A.every 18 months
B.every 12 months
C.every 6 months
D.every 24 months
